PubMed · 1994 · 147 citations · 36 references
MedicineCardiologyImmunologyCardiac TransplantationTransplant ImmunologyTransplant SurgeryCardiovascular DiseaseCardiovascular PathologyCoronary Artery DiseaseHeart TransplantationIschemic Heart DiseaseTransplant RejectionAtherosclerosis RiskCardiac Cell EngraftmentCoronary Atherosclerosis HistopathologyHeart Transplant ImmunogeneticsImmune-mediated Vascular InjuryImmunopathological MechanismsInflammation In Cardiovascular DiseaseTransplant Coronary Artery Disease
An experimental system is described in which coronary arteries of mouse hearts transplanted heterotopically develop obstructive lesions by 4 weeks. Transient immunosuppression permits graft survival. Donor/recipient antigenic differences may be either class I or class II major histocompatibility antigens (H-2) or non-H-2 antigens. An infiltrate including CD4+ and CD8+ T lymphocytes and macrophages concentrates early in the intima and adventitia of larger coronary arteries, with little in the myocardium. Subsequently, the intima expands with cells of donor origin and the infiltrate invades the media. Endothelial and intimal cells express ICAM-1, leukocytes LFA-1: Endothelium expresses class I, but not class II, antigens. As class II disparity alone suffices, the endothelium can apparently be an indirect target of immune injury. We propose that graft atherosclerosis is T cell initiated and elicited by heterogeneous antigens in the endothelium or media. It is separable from rejection of the myocardium.
36
PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE
Robert J. Corry, Henry J. Winn, Paul S. Russell · Transplantation · 1973 · 793 citations
Life Sciences, Immunology, Surgery +17
Variation in susceptibility to atherosclerosis among inbred strains of mice
Beverly Paigen, Ardythe L. Morrow, Charles W. Brandon et al. · Atherosclerosis · 1985 · 611 citations